Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Payables: 2015-2025

Historic Payables for Mesoblast (MESO) over the last 8 years, with Jun 2025 value amounting to $19.1 million.

  • Mesoblast's Payables rose 169.90% to $19.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $48.8 million, marking a year-over-year decrease of 17.26%. This contributed to the annual value of $19.1 million for FY2025, which is 169.90% up from last year.
  • According to the latest figures from Q2 2025, Mesoblast's Payables is $19.1 million, which was up 60.89% from $11.9 million recorded in Q4 2024.
  • In the past 5 years, Mesoblast's Payables registered a high of $24.3 million during Q1 2021, and its lowest value of $7.1 million during Q2 2024.
  • For the 3-year period, Mesoblast's Payables averaged around $15.0 million, with its median value being $15.5 million (2024).
  • As far as peak fluctuations go, Mesoblast's Payables plummeted by 64.90% in 2024, and later spiked by 169.90% in 2025.
  • Quarterly analysis of 5 years shows Mesoblast's Payables stood at $20.9 million in 2021, then increased by 9.91% to $23.0 million in 2022, then plummeted by 53.20% to $10.8 million in 2023, then climbed by 10.22% to $11.9 million in 2024, then skyrocketed by 169.90% to $19.1 million in 2025.
  • Its last three reported values are $19.1 million in Q2 2025, $11.9 million for Q4 2024, and $7.1 million during Q2 2024.